NancyLynnKuntzMD

Child Neurology • Chicago, IL

Associate Professor in Pediatrics and Neurology, Northwestern University Medical School

Join to view full profile

Dr. Kuntz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kuntz's full profile

Already have an account?

Office
225 E. Chicago Ave
Box 51
Chicago, IL 60611
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Child Neurology, 1977 - 1980
Johns Hopkins UniversityResidency, Pediatrics, 1975 - 1977
Boston University School of MedicineClass of 1975

Certifications & Licensure

IL State Medical License 2009 - 2026
HI State Medical License 1986 - 2024
WI State Medical License 2003 - 2011
MN State Medical License 1999 - 2010
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
Unknown status
Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies Start of enrollment: 2010 Feb 01
Completed
Phase 2, Phase 3
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping Start of enrollment: 2012 Apr 01
Unknown status
Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
Completed
Phase 3
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping Start of enrollment: 2012 Sep 01
Unknown status
A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy Start of enrollment: 2014 Apr 17
Completed
Phase 2
A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
Terminated
Phase 3
A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM) Start of enrollment: 2014 Sep 01
Completed
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Start of enrollment: 2015 Oct 08
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Prevalence of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Individuals With Dystrophinopathy at a Tertiary Care Center in Chicago.
Emily Diehl, Meghan O'Neill, Larry Gray, Abigail Schwaede, Nancy Kuntz
Pediatric Neurology. 2024-09-01
A case report of riboflavin transporter deficiency: A novel heterozygous pathogenic variant in thegene.
Elizabeth S Tranel, Bridget McGowan, Andy Drackley, Leon G Epstein, Vamshi K Rao
Molecular Genetics and Metabolism Reports. 2024-03-01
Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy.
Laurey Brown, Katie Hoffman, Chiara Corbo-Galli, Siyuan Dong, Katelyn Zumpf
Journal of Clinical Medicine. 2024-02-06

Press Mentions

Novel Drug May Improve Treatment for Duchenne Muscular DystrophyNovember 9th, 2020
SMA Economic, QoL Burden High in Pre-Treatment EraJune 12th, 2020
Breakthrough Drug Offers Hope for Patients with Debilitating Muscular DiseaseDecember 7th, 2017
Join now to see all